Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02972996 · ClinicalTrials.gov registry record · NA

Blueberry Consumption and Type 2 Diabetes

A NA study of Type2 Diabetes, sponsored by Albany Research Institute.

Completed
Registry status
NA
Development phase
55
Enrollment target
1
Study location

NCT02972996 is a NA study of Type2 Diabetes that has completed, run by Albany Research Institute. The registered enrollment target is 55 participants, below the 47,820-participant average among 20 other Type2 Diabetes trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02972996, a NA study of Type2 Diabetes, has completed, sponsored by Albany Research Institute.

COMPLETED
Registry status
NA
Development phase
55 participants
Enrollment target
1
Study location

Study Summary

Lifestyle strategies that include dietary modification, such as consumption of a plant-based diet, are well recognized in disease prevention and may improve type 2 diabetes. Various components of a plant-based diet may contribute to its beneficial health effects, but there has been keen interest in the possibility that plant polyphenols may have a role. Blueberries are dietary sources of polyphenols, specifically anthocyanins. To date there are few human clinical trials evaluating the beneficial health effects of blueberries in populations with type 2 diabetes. The objective of the study is to determine if freeze-dried blueberries compared to a blueberry placebo will improve cardiometabolic parameters in men with type 2 diabetes.

Conditions Studied

Interventions

  • OTHER Placebo
  • OTHER Blueberry

Study Locations (1)

New York

  • Stratton V.A. Medical Center - Albany

Trial Details

FieldValue
Enrollment Target 55 participants
Start Date 2017-01-19
Est. Completion 2018-06-21
Phase NA

Sponsor

Albany Research Institute

4 total trials

What the Registry Record Tells You About NCT02972996

The ClinicalTrials.gov registry entry for NCT02972996 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 47,820-participant average among 20 other Type2 Diabetes trials with a reported enrollment target (100% lower). The listed sponsor is Albany Research Institute, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type2 Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT02972996 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT02972996 about?

NCT02972996 is a clinical study titled "Blueberry Consumption and Type 2 Diabetes". Lifestyle strategies that include dietary modification, such as consumption of a plant-based diet, are well recognized in disease prevention and may improve type 2 diabetes. Various components of a plant-based diet may contribute to its beneficial health effects, but there has been keen interest in ...

What is the current status of trial NCT02972996?

This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2017-01-19. Estimated completion is 2018-06-21.

What conditions does trial NCT02972996 study?

This clinical trial studies the following conditions: Type2 Diabetes.

What interventions are being tested in trial NCT02972996?

The interventions under investigation include: Placebo (OTHER), Blueberry (OTHER).

Who is sponsoring clinical trial NCT02972996?

This trial is sponsored by Albany Research Institute, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02972996 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type2 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.